Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of an LC-MS/MS Method for ARV-110, a PROTAC Molecule, and Applications to Pharmacokinetic Studies
Authors
Keywords
-
Journal
MOLECULES
Volume 27, Issue 6, Pages 1977
Publisher
MDPI AG
Online
2022-03-21
DOI
10.3390/molecules27061977
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- PROTAC targeted protein degraders: the past is prologue
- (2022) Miklós Békés et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
- (2022) Yue Zhong et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Development and Validation of a Bioanalytical LC-MS/MS Method for Simultaneous Determination of Sirolimus in Porcine Whole Blood and Lung Tissue and Pharmacokinetic Application with Coronary Stents
- (2021) Thi-Thao-Linh Nguyen et al. MOLECULES
- Enteric reabsorption processes and their impact on drug pharmacokinetics
- (2021) Manuel Ibarra et al. Scientific Reports
- Bioanalysis of niclosamide in plasma using liquid chromatography-tandem mass and application to pharmacokinetics in rats and dogs
- (2021) Hae-In Choi et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Inclusion complexation of the anticancer drug pomalidomide with cyclodextrins: fast dissolution and improved solubility
- (2021) Zoltán-István Szabó et al. Heliyon
- First-in-human phase I study of ARV-110, an androgen receptor (AR) PROTAC degrader in patients (pts) with metastatic castrate-resistant prostate cancer (mCRPC) following enzalutamide (ENZ) and/or abiraterone (ABI).
- (2020) Daniel Peter Petrylak et al. JOURNAL OF CLINICAL ONCOLOGY
- Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy
- (2020) Xin Li et al. Journal of Hematology & Oncology
- Determination of KD025 (SLx-2119), a Selective ROCK2 Inhibitor, in Rat Plasma by High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Its Pharmacokinetic Application
- (2020) Jin-Ha Yoon et al. MOLECULES
- Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
- (2020) Andy Pike et al. DRUG DISCOVERY TODAY
- Development of targeted protein degradation therapeutics
- (2019) Philip P. Chamberlain et al. Nature Chemical Biology
- Determination of motolimod concentration in rat plasma by liquid chromatography-tandem mass spectrometry and its application in a pharmacokinetic study
- (2019) Yu-Geun Ji et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Differential regulation of intestinal and hepatic CYP3A by 1α,25‐dihydroxyvitamin D 3 : Effects on in vivo oral absorption and disposition of buspirone in rats
- (2018) Han‐Joo Maeng et al. DRUG DEVELOPMENT RESEARCH
- Liquid chromatography–tandem mass spectrometry of recombinant human extracellular superoxide dismutase (rhSOD3) in mouse plasma and its application to pharmacokinetic study
- (2018) Jong-Woo Jeong et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue
- (2013) Yao Jiang et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors
- (2008) Roula Konsoula et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started